Worcester biotech down to 11 employees after asset sale stalls

The company's recent struggles are tied in part to an ongoing federal government review of its deal to sell manufacturing assets to a Chinese company.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news